BlackRock’s Abiomed Inc ABMD Stock Holding History

BlackRock’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,560,483	Closed	-$1.12B	–	5905
2022 Q3	$1.12B	Buy	4,560,483 +30,854	+0.7%	+$8.33M	0.04%	454
2022 Q2	$1.12B	Sell	4,529,629 -35,124	-0.8%	-$9.48M	0.04%	473
2022 Q1	$1.51B	Sell	4,564,753 -27,813	-0.6%	-$8.56M	0.04%	432
2021 Q4	$1.65B	Buy	4,592,566 +287,541	+7%	+$97.1M	0.04%	433
2021 Q3	$1.4B	Buy	4,305,025 +115,689	+3%	+$39.2M	0.04%	461
2021 Q2	$1.31B	Buy	4,189,336 +53,668	+1%	+$16.5M	0.04%	487
2021 Q1	$1.32B	Buy	4,135,668 +8,309	+0.2%	+$2.66M	0.04%	469
2020 Q4	$1.34B	Buy	4,127,359 +181,751	+5%	+$50.3M	0.04%	426
2020 Q3	$1.09B	Buy	3,945,608 +27,625	+0.7%	+$7.96M	0.04%	426
2020 Q2	$946M	Buy	3,917,983 +144,874	+4%	+$29.1M	0.04%	450
2020 Q1	$548M	Buy	3,773,109 +143,166	+4%	+$23.8M	0.03%	570
2019 Q4	$619M	Buy	3,629,943 +383,693	+12%	+$71.1M	0.02%	673
2019 Q3	$577M	Sell	3,246,250 -143,426	-4%	-$31M	0.02%	659
2019 Q2	$883M	Buy	3,389,676 +290,358	+9%	+$77M	0.04%	477
2019 Q1	$885M	Sell	3,099,318 -65,924	-2%	-$21.9M	0.04%	463
2018 Q4	$1.03B	Buy	3,165,242 +47,673	+2%	+$16.6M	0.05%	349
2018 Q3	$1.4B	Buy	3,117,569 +290,298	+10%	+$114M	0.06%	305
2018 Q2	$1.16B	Sell	2,827,271 -870,264	-24%	-$315M	0.05%	357
2018 Q1	$1.08B	Buy	3,697,535 +172,329	+5%	+$43.7M	0.05%	372
2017 Q4	$661M	Buy	3,525,206 +74,020	+2%	+$13.8M	0.03%	566
2017 Q3	$582M	Buy	3,451,186 +77,531	+2%	+$11.7M	0.03%	580
2017 Q2	$483M	Buy	3,373,655 +103,410	+3%	+$13.9M	0.03%	665
2017 Q1	$409M	Buy	3,270,245 +3,240,638	+10,946%	+$376M	0.02%	762
2016 Q4	$3.34M	Buy	29,607 +8,812	+42%	+$1.02M	﹤0.01%	1049
2016 Q3	$2.67M	Buy	20,795 +2,464	+13%	+$295K	﹤0.01%	1097
2016 Q2	$2M	Buy	18,331 +3,052	+20%	+$304K	﹤0.01%	1166
2016 Q1	$1.45M	Buy	15,279 +13,934	+1,036%	+$1.18M	﹤0.01%	1215
2015 Q4	$122K	Buy	1,345 +260	+24%	+$22.1K	﹤0.01%	1740
2015 Q3	$100K	Buy	1,085 +18	+2%	+$1.59K	﹤0.01%	1727
2015 Q2	$70K	Sell	1,067 -108	-9%	-$7.18K	﹤0.01%	1876
2015 Q1	$84K	Hold	1,175	–	–	﹤0.01%	1813
2014 Q4	$44K	Hold	1,175	–	–	﹤0.01%	1996
2014 Q3	$29K	Hold	1,175	–	–	﹤0.01%	2169
2014 Q2	$30K	Sell	1,175 -36	-3%	-$838	﹤0.01%	2180
2014 Q1	$32K	Hold	1,211	–	–	﹤0.01%	2134
2013 Q4	$33K	Hold	1,211	–	–	﹤0.01%	2106
2013 Q3	$23K	Hold	1,211	–	–	﹤0.01%	2208
2013 Q2	$26K	Buy	+1,211	New	+$24.3K	﹤0.01%	2172

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BlackRock's ABMD Position: Q4 2022 in Review

BlackRock sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,560,483 shares — an estimated $1.12B sold.

BlackRock first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $1.65B in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

BlackRock reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
BlackRock sold 4,560,483 Abiomed Inc shares in Q4 2022, an estimated $1.12B.
BlackRock first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
BlackRock's Abiomed Inc position peaked at $1.65B in Q4 2021.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.